1360186-75-9

Upstream product

• 152120-54-2 N,N'-bis( tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine 
• 13515-95-2 L-lysine methyl ester hydrochloride 
• 308850-43-3 C₁₈H₃₄N₄O₆ 
• 1197285-65-6 (S,Z)-2-benzamido-6-(2,3-bis(tert-butoxycarbonyl)guanidino)hexanoic acid 
• 1197285-64-5 (S,Z)-methyl 2-benzamido-6-(2,3-bis(tert-butoxycarbonyl)guanidino)hexanoate 
• 1360186-66-8 (2R,3S,Z)-tert-butyl 4-ethylidene-2-((S)-1-methoxy-4-methyl-1-oxopentan-2-ylcarbamoyl)-3-methylpyrrolidine-1-carboxylate 
• 1360186-47-5 (2R,3S,Z)-tert-butyl 4-ethylidene-2-(hydroxymethyl)-3-methylpyrrolidine-1-carboxylate 
• 1360186-37-3 (7S,7aR,Z)-6-ethylidene-7-methyltetrahydropyrrolo[1,2-c]oxazol-3(1H)-one 
• 1360186-31-7 (R)-tert-butyl but-2-ynyl(1-hydroxybut-3-en-2-yl)carbamate 

Downstream Products

• 1337555-97-1 (S)-2-{(2R,3S,Z)-1-[(S)-2-benzamido-6-guanidinohexanoyl]-4-ethylidene-3-methylpyrrolidine-2-carboxamido}-4-methyl-pentanoic acid 

Relevant academic research and scientific papers

Rhodium-catalyzed reductive cyclization of 1,6-enynes and stereoselective synthesis of the putative structure of lucentamycin A and its stereoisomers

A Rh-catalyzed diastereoselective reductive cyclization, mediated by hydrogen, of optically active 1,6-enynes using chiral BINAP was successfully applied to the total synthesis of four stereoisomers of the proposed structure of lucentamycin A. In order to